Pooling sputum samples for the Xpert MTB/RIF Ultra assay: A sensitive and effective screening strategy

IF 2.8 3区 医学 Q3 IMMUNOLOGY Tuberculosis Pub Date : 2024-11-08 DOI:10.1016/j.tube.2024.102575
Zhuo Quan , Yong Qiu , Meng Li , Fajun Tian , Rong Qu , Yi-Wei Tang , Xing-Hui Gao , Howard Takiff , Qian Gao
{"title":"Pooling sputum samples for the Xpert MTB/RIF Ultra assay: A sensitive and effective screening strategy","authors":"Zhuo Quan ,&nbsp;Yong Qiu ,&nbsp;Meng Li ,&nbsp;Fajun Tian ,&nbsp;Rong Qu ,&nbsp;Yi-Wei Tang ,&nbsp;Xing-Hui Gao ,&nbsp;Howard Takiff ,&nbsp;Qian Gao","doi":"10.1016/j.tube.2024.102575","DOIUrl":null,"url":null,"abstract":"<div><div>The sensitivity of Xpert MTB/RIF (Xpert) pooled testing is limited for diagnosing patients with paucibacillary tuberculosis (TB). We assessed whether pooled testing with Xpert MTB/RIF Ultra (Ultra) can be a sensitive and effective approach for mass TB screening. Conserved, frozen sputum samples, previously confirmed as positive or negative for <em>Mycobacterium tuberculosis</em> by individual Xpert assays, were mixed in pools of 4, 8, and 16 and then tested using Ultra. Each pool contained a single positive sample with varying mycobacterial loads. We then simulated TB screening at prevalence ranges of 0.2–1.0 % and calculated the cartridges required per case detected at different pool sizes. The overall sensitivity of Ultra pooled testing was high (88.9 %, 75.9–96.3). Sensitivity was greater in pools in which the positive sample had a high mycobacterial load compared to those with scant bacilli. As prevalence increased, the optimal pool size and benefits of pooled testing declined, but a pool size of 8 resulted in at least 80 % cartridge savings with the highest simulated prevalence. Sputum pooling using Ultra could be a sensitive and effective strategy for TB screening. However, broad TB screening in communities with limited resources will require new, lower-cost, high-throughput screening tools, perhaps based on non-sputum specimens.</div></div>","PeriodicalId":23383,"journal":{"name":"Tuberculosis","volume":"149 ","pages":"Article 102575"},"PeriodicalIF":2.8000,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tuberculosis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S147297922400101X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The sensitivity of Xpert MTB/RIF (Xpert) pooled testing is limited for diagnosing patients with paucibacillary tuberculosis (TB). We assessed whether pooled testing with Xpert MTB/RIF Ultra (Ultra) can be a sensitive and effective approach for mass TB screening. Conserved, frozen sputum samples, previously confirmed as positive or negative for Mycobacterium tuberculosis by individual Xpert assays, were mixed in pools of 4, 8, and 16 and then tested using Ultra. Each pool contained a single positive sample with varying mycobacterial loads. We then simulated TB screening at prevalence ranges of 0.2–1.0 % and calculated the cartridges required per case detected at different pool sizes. The overall sensitivity of Ultra pooled testing was high (88.9 %, 75.9–96.3). Sensitivity was greater in pools in which the positive sample had a high mycobacterial load compared to those with scant bacilli. As prevalence increased, the optimal pool size and benefits of pooled testing declined, but a pool size of 8 resulted in at least 80 % cartridge savings with the highest simulated prevalence. Sputum pooling using Ultra could be a sensitive and effective strategy for TB screening. However, broad TB screening in communities with limited resources will require new, lower-cost, high-throughput screening tools, perhaps based on non-sputum specimens.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
为 Xpert MTB/RIF Ultra 检测法汇集痰液样本:灵敏有效的筛查策略。
Xpert MTB/RIF(Xpert)联合检测对诊断贫弱型肺结核(TB)患者的灵敏度有限。我们评估了 Xpert MTB/RIF Ultra(Ultra)联合检测是否能成为一种灵敏有效的大规模结核病筛查方法。将保存的冷冻痰液样本(之前已通过单独的 Xpert 检测确认为结核分枝杆菌阳性或阴性)混合成 4、8 和 16 份样本池,然后使用 Ultra 进行检测。每个样本池中都有一个不同分枝杆菌载量的阳性样本。然后,我们模拟了流行率范围为 0.2-1.0 % 的结核病筛查,并计算了在不同规模的检测池中每个病例所需的试剂盒数量。超级集合检测的总体灵敏度很高(88.9%,75.9-96.3%)。与杆菌数量稀少的样本相比,阳性样本中分枝杆菌数量多的样本池灵敏度更高。随着流行率的增加,最佳的样本池大小和集中检测的益处都在下降,但样本池大小为 8 时,在模拟流行率最高的情况下,至少可节省 80% 的样本盒。使用 Ultra 进行痰液汇集可能是一种灵敏而有效的结核病筛查策略。然而,在资源有限的社区进行广泛的结核病筛查将需要新的、低成本、高通量的筛查工具,或许可以基于非痰标本。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Tuberculosis
Tuberculosis 医学-呼吸系统
CiteScore
4.60
自引率
3.10%
发文量
87
审稿时长
49 days
期刊介绍: Tuberculosis is a speciality journal focusing on basic experimental research on tuberculosis, notably on bacteriological, immunological and pathogenesis aspects of the disease. The journal publishes original research and reviews on the host response and immunology of tuberculosis and the molecular biology, genetics and physiology of the organism, however discourages submissions with a meta-analytical focus (for example, articles based on searches of published articles in public electronic databases, especially where there is lack of evidence of the personal involvement of authors in the generation of such material). We do not publish Clinical Case-Studies. Areas on which submissions are welcomed include: -Clinical TrialsDiagnostics- Antimicrobial resistance- Immunology- Leprosy- Microbiology, including microbial physiology- Molecular epidemiology- Non-tuberculous Mycobacteria- Pathogenesis- Pathology- Vaccine development. This Journal does not accept case-reports. The resurgence of interest in tuberculosis has accelerated the pace of relevant research and Tuberculosis has grown with it, as the only journal dedicated to experimental biomedical research in tuberculosis.
期刊最新文献
Microneedle-mediated intradermal delivery of Bacille Calmette-Guérin (BCG) vaccines for single-dose tuberculosis vaccination. Preclinical model of Mycobacteroides abscessus lung disease by nose-only exposure of mice to bacterial powder aerosol. Utility of pleural fluid-derived extracellular vesicles as a source of Mycobacterium tuberculosis antigens MPT51 and MPT64 for pleural TB diagnosis: a proof-of-concept study. Development of tetracycline analogues with increased aqueous stability for the treatment of mycobacterial infections. A survey of physicians, biomedical researchers and college-educated adults in urban north India about inhaled therapies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1